跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
RIVAROXABAN CIPLA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
RIVAROXABAN CIPLA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Cipla Europe
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 8, 2024
Approval ID
4f30ac89246bd985
Company
Cipla Europe
Type
Standard
Approval Details
Approval Id
4f30ac89246bd985
Drug Cima Aemps Name
RIVAROXABAN CIPLA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89610
Holder Company Name
Cipla Europe
Marketing Company Name
Cipla Europe Nv Sucursal En Espana
Authorization Date
2024-10-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Cipla Europe
Active Ingredients
RIVAROXABAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 8, 2024
Approval ID
4f30ac89246bd985
Type
Standard
Back to CIMA-AEMPS Approvals
RIVAROXABAN CIPLA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details